Insight on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

Type Product title / description Pub Price
Report
Report

R&D Trends: Influenza vaccines - Commoditization limits opportunities in a crowded market

This module discusses R&D Trends in influenza vaccine development in the seven major markets (the US, Japan, France, Germany, Spain, Italy, and the UK).

Published By Datamonitor
05 Aug 2011 $2800
Buy
Report
Report

Epidemiology: Obesity – Set to reach pandemic levels as overweight/obese children become adults

Overview of obesity definitions and a review of epidemiology literature. This report provides and in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
08 Aug 2011 $2800
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally.

Published By Datamonitor
09 Aug 2011 $1520
Buy
Report
Report

Prescribing Influences: Multiple Sclerosis - Therapies that reverse neuronal damage are most sought after

This report analyzes the unmet needs of multiple sclerosis treatment and the attributes of drugs that influence prescribing decisions. The analysis aims to understand the opportunities in the market and support the positioning of marketed brands.

Published By Datamonitor
09 Aug 2011 $2800
Buy
Report
Report

Hot Topics in Type 2 Diabetes: Complications and Comorbidities – Physician insight on diabetic complications, comorbidities and treatment

Datamonitor presents physician primary research on prevalence and development time of complications and comorbidities in type 2 diabetes, and insight on how treatment choices are affected in the US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
17 Aug 2011 $2800
Buy
Report
Report

Epidemiology: COPD – Aging population and stable smoking rates to raise case numbers

Overview of chronic obstructive pulmonary disease, definition, and a review of epidemiology literature. The report provides in-depth analysis of patient populations, 10-year prevalent forecast, and key patient segments across the seven major markets.

Published By Datamonitor
17 Aug 2011 $2800
Buy
Report
Report

Market and Product Forecasts: Systemic Lupus Erythematosus – Benlysta approval kicks off new era in lupus treatment

Benlysta’s US and EU approvals will change the lupus market considerably. With additional products moving through the pipeline, Datamonitor expects to see a significant shift from off- to on-label treatment over the next 10 years.

Published By Datamonitor
22 Aug 2011 $6400
Buy
Report
Report

Product Profiles: Neuropathic Pain - Varied pipeline will fail to yield magic bullet

In-depth analysis of key brands and pipeline agents indicated for the treatment of neuropathic pain. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
26 Aug 2011 $6400
Buy
Report
Report

Generics: Regulatory Update

Datamonitor’s report Generics: Regulatory Update provides an update of changes to generic regulations that occurred in the first half of 2011.

Published By Datamonitor
30 Aug 2011 $1520
Buy
Report
Report

Key Companies: HCV – New market entrants are changing the corporate landscape

This module discusses portfolios and strategies of key companies active in hepatitis C drug development in the seven major markets (the US, Japan, France, Germany, Spain, Italy, and the UK).

Published By Datamonitor
30 Aug 2011 $2800
Buy

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

No help is available.